Drawing for VERESCA

USPTO serial 79282811

VERESCA

Reviewed by CopyMark Law Group

Reg. 6816756Status 700Registered
Filing date
Status date
Registration date
Aug 16, 2022
Examiner
SEVERSON, JUSTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VERESCA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rita E. Kline

Rita E. Kline Renner, Otto, Boisselle & Sklar, LLP1621 Euclid AvenueFloor 19CLEVELAND, OH 44115

Goods and services

ClassDescriptionStatusFirst use
005Clinical diagnostic reagents for medical purposes; diagnostic agents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; diagnostic testing materials for medical use, namely, materials for testing antibodies; reagents for use in diagnostic testing for medical purposesACTIVE—
044Providing breast cancer screening services; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; medical laboratory services for the analysis of samples taken from patients; medical services in the field of oncology; medical testing services relating to the diagnosis and treatment of disease; pathology services for the diagnosis and treatment of diseases; performing diagnosis of diseases; providing prostate cancer screening services; providing cancer screening services; providing information relating to medical services; providing medical information; providing medical information in the healthcare sector; analysis of human tissues for medical treatment; chemotherapy services; medical analysis for the diagnosis and treatment of persons; medical analysis services relating to the treatment of persons provided by a medical laboratory, namely, medical diagnostic testing, monitoring and reporting services in the field of oncology; medical care and analysis services relating to patient treatment; medical counselling; medical diagnostic services in the nature of breast cancer screening; medical analysis services relating to the treatment of patients; medical consultations; medical testing for diagnostic or treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 21, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 6, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 6, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 6, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 6, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 11, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 22, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 22, 2022FIMPFINAL DISPOSITION PROCESSED—
Nov 16, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 16, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 16, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 31, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 30, 2022GPNXNOTIFICATION PROCESSED BY IB—
May 11, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 11, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 11, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 21, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Apr 21, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 21, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 21, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 13, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 5, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 5, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 5, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 5, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 5, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 5, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 3, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 15, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 15, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 29, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 29, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Mar 29, 2021CNSLSUSPENSION LETTER WRITTEN—
Mar 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 23, 2021ALIEASSIGNED TO LIE—
Dec 18, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 16, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 16, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 16, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 16, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 10, 2020RFNTREFUSAL PROCESSED BY IB—
Jun 22, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 22, 2020RFRRREFUSAL PROCESSED BY MPU—
May 20, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 19, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 13, 2020DOCKASSIGNED TO EXAMINER—
Apr 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance